Latest Period
n/a
Security Snapshot
Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) Institutional Ownership
CUSIP: 49372L100
13F Institutional Holders and Ownership History from Q2 2018 to Q4 2025
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- KZR on Nasdaq
- Shares outstanding
- 7,393,623
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 49372L100.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
- SEC-reported value moved from $1 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
49372L100
Latest holder period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
KZR full holder history
Kezar Life Sciences, Inc. SEC filings
Kezar Life Sciences, Inc. company facts
Kezar Life Sciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 49372L100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
KZR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Equal Talent Investments Ltd | 8.7% | $487,037 | 616,502 | Equal Talent Investments Limited | 28 Feb 2025 | |||
| Avidity Partners Management LP | 6.9% | $397,054 | 502,600 | Avidity Partners Management LP | 31 Dec 2024 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
n/a
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$1 | 0 | |
| 2025 Q3 | 1 | $1 | +$1 | $1.00 | 1 |
| 2025 Q1 | 0 | $0 | -$2,838 | 0 | |
| 2024 Q4 | 0 | $0 | -$28,947,595 | 0 | |
| 2024 Q3 | 37,449,865 | $28,947,595 | +$900,937 | $0.77 | 54 |
| 2024 Q2 | 39,365,394 | $23,615,883 | -$3,995,490 | $0.60 | 77 |
| 2024 Q1 | 44,720,608 | $40,307,361 | -$4,363,680 | $0.90 | 80 |
| 2023 Q4 | 49,383,993 | $46,782,011 | -$6,015,885 | $0.95 | 81 |
| 2023 Q3 | 55,483,503 | $66,015,535 | -$3,021,557 | $1.19 | 81 |
| 2023 Q2 | 56,853,940 | $139,289,225 | -$10,696,353 | $2.45 | 102 |
| 2023 Q1 | 60,086,283 | $188,069,347 | -$2,895,034 | $3.13 | 135 |
| 2022 Q4 | 57,438,478 | $404,373,495 | -$10,789,742 | $7.04 | 123 |
| 2022 Q3 | 57,567,548 | $495,653,323 | +$24,341,050 | $8.61 | 131 |
| 2022 Q2 | 54,911,473 | $454,020,310 | +$61,154,299 | $8.27 | 125 |
| 2022 Q1 | 44,191,085 | $734,149,889 | +$63,780,372 | $16.62 | 121 |
| 2021 Q4 | 39,383,430 | $658,088,801 | +$203,357,999 | $16.72 | 103 |
| 2021 Q3 | 28,072,081 | $242,729,438 | +$7,811,950 | $8.64 | 75 |
| 2021 Q2 | 27,643,703 | $150,101,213 | +$4,146,701 | $5.43 | 73 |
| 2021 Q1 | 26,470,809 | $157,211,005 | +$18,317,371 | $5.96 | 79 |
| 2020 Q4 | 23,537,490 | $122,866,361 | +$1,908,188 | $5.22 | 75 |
| 2020 Q3 | 23,177,080 | $112,175,583 | -$609,875 | $4.84 | 75 |
| 2020 Q2 | 23,193,481 | $119,558,636 | +$25,836,495 | $5.18 | 82 |
| 2020 Q1 | 18,491,349 | $80,617,885 | +$40,696,616 | $4.36 | 58 |
| 2019 Q4 | 9,173,287 | $36,785,829 | -$692,653 | $4.01 | 54 |
| 2019 Q3 | 9,424,823 | $30,911,164 | -$5,442,310 | $3.28 | 53 |